The goals of Project 2 are to define the natural history and biological substrate of age-associated cognitive decline in humans and to distinguish these features from those occurring in Alzheimer's disease (AD). To this end, we plan to characterize age-related alterations in memory and cognition in a cohort of elderly nondemented subjects in the Baltimore Longitudinal Study of Aging and to analyze neuropathological/neurochemical changes in the brains of these and other individuals, ranging in age from the second to the ninth decades. In these brains, we will map the distribution of pathology in the amygdala, hippocampus, dorsomedial nucleus of the thalamus, and prefrontal cortex - - anatomical structures known to play important roles in memory and learning, cognitive functions that decline in older individuals. Combining classical and new techniques, we will first determine the course of development of senile plaques and neurofibrillary tangles. subsequently, we will examine relationships between expression of the beta-amyloid precursor protein gene and neurofilament genes and their proteins in the development of plaques and tangles. To determine whether nerve cells degenerate and die or whether their sizes decrease with age, we will use computerized morphometry to analyze selected cell populations in hippocampus and neocortex. In parallel, to probe a functional parameter of neurons, we will measure age-associated alterations in levels of neurotransmitter markers. Finally, we plan to compare the distribution of abnormalities that occur in the brains of neuropsychologically characterized, nondemented aged individuals to patterns of changes that occur in subjects with AD. This comparison should yield useful information to delineate pathogenetic hypotheses for AD and, at the same time, to allow more satisfactory definition of diagnostic criteria useful for separating the pathology of aging from that of AD. Thus, Project 2 will provide insights into the nature and biological substrate of cognitive decline in aging, will offer clues to the pathogenesis of degenerative processes that occur in aging, and will clarify boundaries between normal aging and AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-08
Application #
3809228
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Tsapkini, Kyrana; Webster, Kimberly T; Ficek, Bronte N et al. (2018) Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial. Alzheimers Dement (N Y) 4:461-472
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Riello, Marianna; Faria, Andreia V; Ficek, Bronte et al. (2018) The Role of Language Severity and Education in Explaining Performance on Object and Action Naming in Primary Progressive Aphasia. Front Aging Neurosci 10:346
Chen, Lin; Wei, Zhiliang; Chan, Kannie W Y et al. (2018) Protein aggregation linked to Alzheimer's disease revealed by saturation transfer MRI. Neuroimage 188:380-390
Ayhan, Fatma; Perez, Barbara A; Shorrock, Hannah K et al. (2018) SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F. EMBO J 37:
Sathe, Gajanan; Na, Chan Hyun; Renuse, Santosh et al. (2018) Phosphotyrosine profiling of human cerebrospinal fluid. Clin Proteomics 15:29
Martin, Lee J; Chang, Qing (2018) DNA Damage Response and Repair, DNA Methylation, and Cell Death in Human Neurons and Experimental Animal Neurons Are Different. J Neuropathol Exp Neurol 77:636-655

Showing the most recent 10 out of 830 publications